Kawamura Nobuyuki | European Federation of Pharmaceutical Industries and Associations
スポンサーリンク
概要
関連著者
-
Kawamura Nobuyuki
European Federation of Pharmaceutical Industries and Associations
-
Kawamura Naohisa
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Kai Shuichi
東京都健康安全研究センター
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Sagami Fumio
第一三共安全性研究所
-
Sagami Fumio
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Sagami Fumio
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Sagami Fumio
Japan Pharmaceutical Manufacturers Association (jpma) Qt Prodact
-
Sagami Fumio
Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.
-
Onodera Hiroshi
東京都健康安全研究センター
-
小野寺 博志
Division Of Pathology National Institute Of Health Sciences
-
Onodera Hiroshi
Pharmaceuticals And Medical Devices Agency
-
Ohno Yasuo
第一三共安全性研究所
-
Ohno Yasuo
National Institute of Health Sciences
-
Nakazawa Takahiro
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Kurokawa Misao
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Shinoda Kazutoshi
Pharmaceuticals and Medical Devices Agency
-
Yamazaki Tsuneyoshi
Kyoritsu University of Pharmacy, Kyoritsu University of Pharmacy
-
Kawai Mutsufumi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Nakazawa Takahiro
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Onodera H
Pharmaceuticals And Medical Devices Agency
-
Kurokawa Misao
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Takeshita Shuji
Drug Safety Evaluation Lead Optimizaion Drug Innovation & Approval Divistion Aventis Pharma Ltd.
-
Yamazaki Tsuneyoshi
Kyoritsu University Of Pharmacy Kyoritsu University Of Pharmacy
-
Komori Masayuki
Division Of Analytical Biochemistry Faculty Of Pharmaceutical Sciences Hokkaido University
-
Ohno Yasuo
National Inst. Of Health Sci. Tokyo Jpn
-
Onodera Hiroshi
Dvision Of Pathology Biological Safety Research Center National Institute Of Health Sciences
-
Tsutsumi Shunsuke
Drug Development Research Laboratories, Pharma Research and Development Division, Hoechst Japan Limi
-
Kudo Satoshi
Res. Center Kyorin Pharmaceutical Co. Ltd.
-
KAWAMURA Nobuyuki
Drug Safety Evaluation, Lead Optimization, Drug Innovation & Approval Division, Aventis Pharma Ltd.
-
Tsutsumi S.
日本製薬工業協会
-
Ohno Yasuo
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
Onodera Hiroshi
Pharmaceutical And Medical Devices Agency
-
Takayama Satoshi
Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co.ltd.
-
INOUE Tadashi
Japan Pharmaceutical Manufactures Association
-
Inoue Tohru
Biological Safety Research Center, National Institute of Health Sciences
-
Kimura Kazuya
Japan Pharmaceutical Manufacturers Assoc. Drug Evaluation Committee Non-clinical Evaluation Subcommi
-
Hisada Shigeru
Safety Research Department Developmental Research Center, ASKA Pharmaceutical Co., Ltd.
-
HISADA SHIGERU
Japan Pharmaceutical Manufacturers Association
-
WAKATA AKIHIRO
Japan Pharmaceutical Manufacturers Association
-
Yoshida Takemi
Showa Univ.
-
Hisada Shigeru
Safety Research Department Developmental Research Center Aska Pharmaceutical Co. Ltd.
-
Hisada Shigeru
Safety Research Department Aska Pharmaceutical Co. Ltd.
-
Heidel Shawn
Eli Lilly, Eli Lilly and Company
-
Kawakami Koji
Kyoto University
-
Kumagai Yuji
Showa University, School of Pharmaceutical Sciences
-
Inoue Tohru
National Institute of Health Sciences
-
Fueki Osamu
Pharmaceuticals and Medical Devices Agency
-
NAITO Shinsaku
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
FURUTA Shigeru
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
KITADA Mitsukazu
Chiba University Hospital
-
UNNO Takashi
Pharmaceutical Research and Manufactures of America
-
Takayama Satoshi
Drug Safety Research Center Developmental Research Lab. Daiichi Pharmaceutical Co. Ltd.
-
Takayama S
Saitama Daiichi Pharmaceutical Co. Ltd.
-
Takayama Satoshi
Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
Takayama Satoshi
Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
Takayama Satoshi
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
YAMAUCHI Hitoshi
Research Department, Saitama Daiichi Pharmaceutical Co., Ltd.
-
SHINKAI Norihiro
Research Department, Saitama Daiichi Pharmaceutical Co., Ltd.
-
Kawakami Koji
Dep. Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto Univ.
-
Yamauchi Hitoshi
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
Kimura Kazuya
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Shinkai Norihiro
Research & Development Department Nipro Patch Co. Ltd.
-
Inoue Tadashi
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Fueki Osamu
Pharmaceuticals And Medical Devices Agency Shin-kasumigaseki Building
-
Takayama S
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
Kumagai Yuji
Showa University School Of Pharmaceutical Sciences
-
Heidel Shawn
Eli Lilly Eli Lilly And Company
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Furuta Shigeru
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Wakata Akihiro
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Shinkai N
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
YAMAIICHI Hitoshi
Research Department, Saitama Daiichi Pharmaceutical Co., Ltd.
-
Yoshida Takemi
Showa University School Of Pharmaceutical Sciences
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Yamaiichi Hitoshi
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
Inoue Tohru
Biological Safety Research Center National Institute Of Health Sciences
-
Takada Sanae
Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co.ltd.
-
Inoue Tohru
National Institute Of Health Science
著作論文
- Safety assessment of biopharmaceuticals : Japanese perspective on ICH S6 guideline maintenance
- CURRENT OPINION : SAFETY EVALUATION OF DRUG METABOLITES IN DEVELOPMENT OF PHARMACEUTICALS
- COMPARISON OF POULTICE-TYPE AND TAPE-TYPE PATCHES CONTAINING KETOPROFEN ON HUMAN SKIN IRRITATION
- P-83 Collaborative work for evaluation of toxicity on male reproductive organs by repeated dose studies in rats : Effects of daily subcutaneous administration of reserpine on spermatogenesis for 2 and 4 weeks(Proceedings of the 27th Annual Meeting)
- COLLABORATIVE WORK TO EVALUATE TOXICITY ON MALE REPRODUCTIVE ORGANS BY REPEATED DOSE STUDIES IN RATS : 8)EFFECTS OF DAILY SUBCUTANEOUS ADMINISTRATION OF RESERPINE ON SPERMATOGENESIS FOR 2 AND 4 WEEKS